Literature DB >> 1363418

Genitourinary and sexual adverse effects of psychotropic medication.

M H Pollack1, S Reiter, P Hammerness.   

Abstract

OBJECTIVE: We review the adverse effects on genitourinary and sexual function associated with antidepressants, neuroleptics, lithium, and benzodiazepines, and suggest treatment strategies that may be used for their management.
METHOD: This article is based on systematic review of the existing literature, including more than 130 relevant articles on genitourinary and sexual effects of psychotropic medications.
RESULTS: We find that genitourinary function, including effects on continence and flow, and sexual function, including libido, erection, ejaculation and orgasm, may be altered by psychotropic administration. Many of these effects may be consequent to the impact of these medications on neurophysiologic systems.
CONCLUSIONS: Genitourinary and sexual adverse effects associated with psychotropic therapy are important areas of study and clinical concern that may affect patient comfort and compliance with treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1363418     DOI: 10.2190/P60R-PLED-TL09-TUEN

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  13 in total

1.  Bowel dysfunction in young women.

Authors:  E H Friedman
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

Review 2.  A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy.

Authors:  Mariana S Sousa; Michelle Peate; Sherin Jarvis; Martha Hickey; Michael Friedlander
Journal:  Ther Adv Med Oncol       Date:  2017-01-31       Impact factor: 8.168

Review 3.  First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Authors:  Deanna L Kelly; Robert R Conley; William T Carpenter
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.

Authors:  S L Clark; D E Adkins; K Aberg; J M Hettema; J L McClay; R P Souza; E J C G van den Oord
Journal:  Psychol Med       Date:  2011-11-01       Impact factor: 7.723

5.  Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.

Authors:  D E Adkins; S L Clark; K Åberg; J M Hettema; J Bukszár; J L McClay; R P Souza; E J C G van den Oord
Journal:  Transl Psychiatry       Date:  2012-07-03       Impact factor: 6.222

6.  Sexual dysfunction with the use of antidepressants in a tertiary care mental health setting - a retrospective case series.

Authors:  Kingshuk Lahon; Harsha M Shetty; Amith Paramel; Gyaneswar Sharma
Journal:  J Pharmacol Pharmacother       Date:  2011-04

7.  Validation of sexual functioning questionnaire in Indian patients.

Authors:  Kodakandla Krishna; Ajit Avasthi; Sandeep Grover
Journal:  Indian J Psychol Med       Date:  2014-10

8.  Prevalence and pattern of sexual dysfunction in married females receiving antidepressants: An exploratory study.

Authors:  Sandeep Grover; Ruchita Shah; Alakananda Dutt; Ajit Avasthi
Journal:  J Pharmacol Pharmacother       Date:  2012-07

9.  Effects of pharmaceutical medications on male fertility.

Authors:  Paul R Brezina; Fahd N Yunus; Yulian Zhao
Journal:  J Reprod Infertil       Date:  2012-01

10.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.